Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection
2005
Majority of HIV/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals
2015
In vitro antimicrobial activity of ten medicinal plants against clinical isolates of oral cancer cases
2011
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014
2016 Standout
Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral Therapy
2004
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients
2008
Fusobacterium necrophorum as the cause of recurrent sore throat: comparison of isolates from persistent sore throat syndrome and Lemierre's disease
2004
Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible
2014 Standout
Impact of Fluoroquinolone Prophylaxis on Reduced Infection‐Related Mortality among Patients with Neutropenia and Hematologic Malignancies
2005
Liver Transplantation in Hiv-Infected Recipients
2005
Burden of liver diseases in the world
2018 Standout
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Limitations of a Simplification Antiretroviral Strategy for HIV-Infected Patients with Decreasing Adherence to a Protease Inhibitor Regimen
2006
Factors Associated with the Emergence of K65R in Patients with HIV‐1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir
2008
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections
2009
Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts*
2008
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
The expanding scope of DNA sequencing
2012
Antibiotic prophylaxis in neutropenic patients
2006
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
2008 Standout
Couple-focused support to improve HIV medication adherence: a randomized controlled trial
2005
Deep sequencing: Becoming a critical tool in clinical virology
2014
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection
2003
Lipodystrophy Syndromes
2008
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance
2006
Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial
2012
Treatment for Adult HIV Infection
2006
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
2011 Standout
Essential oils from aromatic herbs as antimicrobial agents
2011 Standout
Pathogenic Escherichia coli
2004 Standout
Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-ResistantEscherichia coliClonal Group
2001
Dynamics and functions of lipid droplets
2018 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Effect of Ascites on Tacrolimus Disposition in a Liver Transplant Recipient
2001
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review
2009
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
2007
Anaerobes: Antibiotic resistance, clinical significance, and the role of susceptibility testing
2005
The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients
2004
Treatment for Adult HIV Infection
2004
The etiology of urinary tract infection: traditional and emerging pathogens
2002
Uncomplicated Urinary Tract Infection
2012 Standout
Immunogenetics of HIV and HIV associated tuberculosis
2011
Sexually transmitted diseases treatment guidelines
2003 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Efficacy and Durability of Nevirapine in Antiretroviral Drug Naïve Patients
2003
Special Invited Papers Section: Therapeutic Equivalence – Clinical Issues and Statistical Methodology in Noninferiority Trials
2005
Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects
2009
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets
2017 Standout
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
2001
Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients
2008
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Epidemiology of urinary tract infections
2003
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
2020 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution
2008
Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
2009
Not All Missed Doses Are the Same: Sustained NNRTI Treatment Interruptions Predict HIV Rebound at Low-to-Moderate Adherence Levels
2008
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection
2000
Emerging anti-HIV drugs
2005
Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data
2003
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia
2005
Industry sponsorship and research outcome
2012 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Multiple roles of the coagulation protease cascade during virus infection
2014
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders
2004
Interventions for enhancing medication adherence
2008 Standout
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy
2017
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
2006
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Interventions for enhancing medication adherence
2014 Standout
The Immune Response in Tuberculosis
2013 Standout
New antimicrobial agents for the treatment of bacterial infections in cancer patients
2009
The etiology of urinary tract infection: Traditional and emerging pathogens
2003
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance
2009
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
2009
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
2012 Standout
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Industry sponsorship and research outcome
2017 Standout
Works of David Dalmau being referenced
HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
2013
Failure of Cetirizine to Prevent Nevirapine-Associated Rash
2004
All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection
2012
Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection
2003
Clindamycin Resistance in the Bacteroides fragilis Group: Association with Hospital-Acquired Infections
1997
Spanish HIV-1-Infected Long-Term Nonprogressors of More Than 15 Years Have an Increased Frequency of the CX3CR1 249I Variant Allele
2005
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients
2007
Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects
2011
Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin‐resistant Escherichia coli
2003
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir
2001
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study
1999
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study
2000
Cefotaxime, Desacetyl‐Cefotaxime, and Bactericidal Activity in Spontaneous Bacterial Peritonitis
1999
Escherichia coli Serotype O15:K52:H1 as a Uropathogenic Clone
2000
[Metronidazole and angina caused by infectious mononucleosis].
1993
Early Virological Failure with a Combination of Tenofovir, Didanosine and Efavirenz
2005
Comparison of Immunologic Restoration and Virologic Response in Plasma, Tonsillar Tissue, and Cerebrospinal Fluid in HIV-1–Infected Patients Treated With Double Versus Triple Antiretroviral Therapy in Very Early Stages: The Spanish Earth-2 Study
2000